Skip to main content
Premium Trial:

Request an Annual Quote

Noninvasive Endometriosis Test Developer DotLab Secures $10M in Series A Funding

NEW YORK – Women's health personalized medicine company DotLab said on Monday it has secured $10 million in Series A funding.

The San Francisco-based firm is combining noninvasive microRNA biomarkers with machine learning to develop a noninvasive test for endometriosis. In a statement, DotLab CEO Heather Bowerman said that the company will use the funds to "further clinical validation, expand market access, and continue to grow our team."

CooperSurgical, a business unit of The Cooper Companies, led the financing, which also included individual investors from Tiger Global Management, Luxor Capital Group, and the law firm Wilson Sonsini Goodrich & Rosati.

The DotLab test detects microRNA biomarkers, but it is not a genetic test for endometriosis, and the risk profiles do not confirm active disease, Bowerman said in an email.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.